Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Market Capitalization (2018 - 2026)

Analysis

Kodiak Sciences (KOD) Market Capitalization (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.45 Bn
Mar 31, 2026 2.37 Bn
Dec 31, 2025 1.73 Bn
Sep 30, 2025 867.59 Mn
Jun 30, 2025 197.02 Mn
Mar 31, 2025 148.23 Mn
Dec 31, 2024 524.63 Mn
Sep 30, 2024 137.35 Mn
Jun 30, 2024 123.64 Mn
Mar 31, 2024 276.27 Mn
Dec 31, 2023 159.63 Mn
Sep 30, 2023 94.44 Mn
Jun 30, 2023 361.93 Mn
Mar 31, 2023 324.54 Mn
Dec 31, 2022 374.71 Mn
Sep 30, 2022 404.83 Mn
Jun 30, 2022 397.47 Mn
Mar 31, 2022 400.98 Mn
Dec 31, 2021 4.39 Bn
Sep 30, 2021 4.96 Bn